Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

12 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Bortezomib Bortezomib 1件: D03150 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
2 Bortezomib (velcade®) Bortezomib 1件: D03150 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 66 💬
3 Bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 283 💬
4 Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
5 Combination of a single dose anti-cd20 antibody and bortezomib Bortezomib 1件: D03150 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 61 💬
6 Cyclophosphamide, bortezomib, and dexamethasone (cybord) Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
7 Cyclophosphamide, bortezomib, dexamethasone Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
8 Cyclophosphamide, bortezomib, dexamethasone plus daratumumab Bortezomib 13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬 3件: CD38, NR3C1, PSMB5 💬 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 1件: 28 💬
9 Velcade - - - - 5件: 11, 28, 46, 49, 61 💬
10 Velcade*1fl 3,5mg - - - - 1件: 28 💬
11 Velcade*ev 1fl 3,5mg 1mg/ml - - - - 1件: 61 💬
12 Velcade® - - - - 3件: 11, 46, 49 💬